EcoDrugPlus

Natriuretic Peptide Receptor 1a

Ensembl ID : ENSTNIG00000004620
Gene Symbol: NPR1A
2 Cross references
155 Possible Orthologues:

Natriuretic Peptide Receptor 2

Ensembl ID : ENSTNIG00000006188
Gene Symbol: NPR2
2 Cross references
191 Possible Orthologues:

Natriuretic Peptide Receptor 3

Ensembl ID : ENSTNIG00000002699
Gene Symbol: NPR3
2 Cross references
211 Possible Orthologues:

Neuropeptide Y Receptor Y2

Ensembl ID : ENSTNIG00000007120
Gene Symbol: NPY2R
2 Cross references
184 Possible Orthologues:

Neuropeptide Y Receptor Y4

Ensembl ID : ENSTNIG00000016553
Gene Symbol: NPY4R
2 Cross references
135 Possible Orthologues:

Neurotensin Receptor 1

Ensembl ID : ENSTNIG00000002761
Gene Symbol: NTSR1
3 Cross references
203 Possible Orthologues:

Neurotrophic Receptor Tyrosine Kinase 2

Ensembl ID : ENSTNIG00000015792
Gene Symbol: NTRK2
2 Cross references
207 Possible Orthologues:

Neurotrophic Receptor Tyrosine Kinase 3

Ensembl ID : ENSTNIG00000011911
Gene Symbol: NTRK3
2 Cross references
193 Possible Orthologues:

Neurotrophic Tyrosine Kinase, Receptor, Type 1

Ensembl ID : ENSTNIG00000010301
Gene Symbol: NTRK1
2 Cross references
199 Possible Orthologues:

Neurotrophic Tyrosine Kinase, Receptor, Type 2b

Ensembl ID : ENSTNIG00000007553
Gene Symbol: NTRK2B
2 Cross references
207 Possible Orthologues:

Nfe2 Like Bzip Transcription Factor 2a

Ensembl ID : ENSTNIG00000016959
Gene Symbol: NFE2L2A
2 Cross references
216 Possible Orthologues:

Nicastrin

Ensembl ID : ENSTNIG00000004593
Gene Symbol: NCSTN
3 Cross references
203 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).